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Abstract
Retinoic acid (RA), which was injected within 4 h after partial hepatectomy (PH), inhibited DNA synthesis in regenerating
liver. The inhibition was accompanied by apoptosis, evidenced by in situ end labeling and gel electrophoresis of DNA
fragmentation. Characteristic DNA fragmentation was obvious at 4 h and reached a maximum at 8 h after injection.
Northern blot analysis revealed that RA repressed the expression of c-fos and c-jun at 15 and 30 min with the up-regulation
of retinoic acid receptor Q (RARQ) and RARL at 2 h after PH. The transglutaminase II mRNA level and activity were
increased by RA injection at 4 h and 8 h after PH, respectively. The mRNA levels of thymidylate synthase and thymidine
kinase, which are rate determining enzymes of DNA synthesis, decreased in RA injected rats. No change was seen in the
expression of p53 and p21WAF1=CIP1 which have been suggested to participate in the apoptosis process. These results suggest
that RA exerts the antiproliferative activity only on the early stage of liver regeneration accompanied by the repression of
c-fos and c-jun expression and induction of apoptosis. ß 1999 Elsevier Science B.V. All rights reserved.
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1. Introduction
Retinoic acid (RA), a physiological metabolite of
vitamin A, has potent e¡ects on many biological
functions, such as proliferation, di¡erentiation and
fetal development [1,2]. RA has been used as chemo-
therapeutic agents because of its strong antiprolifer-
ative activity against certain types of cancers [3].
Similarly, many tissue culture cells undergo di¡eren-
tiation in response to RA treatment. RA stimulates
apoptosis in cultured HL60 human promyelocytes,
neuroblastoma and breast cancer cell lines [4^6].
Thus, the antiproliferative e¡ects of RA has been
studied primarily in tumor cell lines and signi¢cant
di¡erences exist between cell types. Very little is
known about the e¡ects of RA on normal cells.
The purpose of this study was to examine the e¡ects
of RA on the normal cell proliferation.
The regenerating liver following two-thirds partial
hepatectomy (PH) in the rat is considered one of the
most feasible models to study the cellular changes
occurring in vivo in di¡erent phases of the cell cycle
of normal cell proliferation because of the relevant
synchronism of the ¢rst cell cycle, the timing of
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which has been well established [7]. After PH, most
remaining hepatocytes promptly enter and progress
in the cell cycle in a synchronous manner [8]. The
¢rst ‘priming’ stage, in which hepatocytes undergo a
transition from a resting state (G0) to one in which
they become capable of proliferating if the appropri-
ate inducer is present (G1), is characterized by an
increase in the expression of the immediate early re-
sponse genes such as c-fos and c-jun [9,10]. The pri-
ming stage encompasses the ¢rst 4^6 h after PH. The
‘primed’ hepatocytes then enter a ‘progression’ stage
characterized by an increase in p53 mRNA. After a
prereplicative phase of the priming and progression
stage lasting 12^16 h, the expression of thymidylate
synthase (TS; EC 2.1.1.45) and thymidine kinase
(TK; EC 2.7.1.21) which are rate determining en-
zymes of DNA synthesis [11], is induced at the G1/
S boundary [12,13]. DNA synthesis starts at about
18 h after PH and peaks at 24 h. Using this model,
we investigated the e¡ects of RA on the normal cell
proliferation and the expression of cell cycle associ-
ated genes.
The induction of apoptosis by retinoids is related
to cell growth and di¡erentiation in various ways,
depending on cell type. Growth arrest by retinoids
can lead to either terminal di¡erentiation or apopto-
sis [14]. Retinoids ¢rst induced di¡erentiation, and
then the di¡erentiated cells underwent apoptosis as
exempli¢ed by HL-60 myeloid leukemia cells [4],
while apoptosis was induced in a process that was
independent of di¡erentiation in neuroblastoma cells
[5]. In F9 embryonal carcinoma cells and p39 mye-
lomonocytic leukemia cells, retinoids induced di¡er-
entiation and apoptosis concurrently [15,16]. A syn-
thetic retinoid induced G0/G1 arrest and apoptosis in
human breast cancer cells [17]. G1 arrest and apop-
tosis by RA were also observed in human neuroblas-
toma cells [18]. RA caused accumulation of Hep 3B
hepatocellular carcinoma cells in sub-G1 phase and
induced apoptosis [19]. These suggest that the start-
ing point for apoptosis could be related to speci¢c
phase of the cell cycle as well as the di¡erentiation
stage. It is important to elucidate when and how
RA switches on the apoptosis and to de¢ne this
process in terms of changes in expression of speci¢c
genes.
In the present study we evaluated the antiprolifer-
ative e¡ect of RA and the RA induced apoptosis
focusing on the cell cycle related gene expression
during liver regeneration. The results showed that
RA exerted anti-proliferative activity only at the pri-
ming stage of liver regeneration accompanied by the
repression of the c-fos and c-jun expression and in-
duction of apoptosis.
2. Materials and methods
2.1. Materials
The reagents were purchased from the following
sources: [methyl-3H]thymidine (60 Ci/mmol), ICN
Biomedicals; [5-3H]deoxyuridine monophosphate
(14.8 Ci/mmol), Amersham; [2,3-3H(N)]putrescine
(80 Ci/mmol), ARC; DIG RNA labeling kit and
DIG luminescent detection kit, Boehringer Mann-
heim; Oligo(dT)cellulose (type 3), Collaborative
Research; Gene screen nylon membrane, NEN Re-
search Products. All other reagents were of analytical
grade.
2.2. Animals
Male Wistar rats weighing 180^200 g were used for
all experiments. The animals were kept in tempera-
ture controlled rooms with 12 h alternating light and
dark cycles and given commercial laboratory chow
(MF, Oriental Yeast, Osaka, Japan) and water ad
libitum. Two-thirds partial hepatectomy (PH) was
performed by the procedure of Higgins and Ander-
son [20]. RA (15, 2 or 0.5 mg/kg body weight), dis-
solved in corn oil/dimethylsulfoxide (1:1), was intra-
peritoneally injected immediately or at indicated
times after PH. Control rats received the same quan-
tity of the vehicle as the experimental animals. The
rats were killed under diethyl ether anaesthesia and
their livers were excised at indicated times.
2.3. Determination of the enzyme activities and
contents of DNA, RNA and protein
The excised liver was homogenized with 5 volumes
of 50 mM Tris-HCl bu¡er (pH 7.3) containing
0.25 M sucrose, 10 mM L-mercaptoethanol, 1 mM
phenylmethylsulfonyl £uoride and 1 mM EDTA. TS
and TK activities of the supernatant fraction of a
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20% liver homogenate were determined and ex-
pressed as pmol of product formed/min per mg pro-
tein at 37‡C as described previously [11]. The activity
of serum glutamate-oxaloacetate transaminase
(GOT; EC 2.6.1.1) was measured spectrophotometri-
cally utilizing diagnostic kits (Wako, Osaka, Japan)
and expressed as IU at 25‡C. The TGase II activity
of the liver homogenate was measured by detecting
the incorporation of [3H]putrescine into N,NP-dime-
thylcasein [21]. Protein was measured by the method
of Lowry et al. [22] with bovine serum albumin as
standard. The DNA and RNA contents of the liver
were measured by the diphenylamine [23] and orcin
reactions [24], respectively, after extraction with tri-
chloroacetic acid according to the procedure of
Schneider [24]. Statistical analyses of data were
done with one-way analysis of variance with pairwise
comparison by the Bonferroni method [25].
2.4. In situ end labeling of 3P-OH ends of DNA
fragments
Paraformaldehyde ¢xed para⁄n embedded liver
sections, obtained from the regenerating liver of con-
trol and RA injected rats at 8 h after PH were proc-
essed for in situ detection of DNA fragmentation by
the terminal deoxynucleotidyl transferase (TdT)
mediated nick end labeling technique (TUNEL) [26]
using the In Situ Cell Death Detection kit (Boeh-
ringer-Mannheim, Germany). Brie£y, depara⁄nized
tissue sections were enzymatically labeled with £uo-
rescein-nucleotide via terminal deoxynucleotidyl
transferase and subsequently exposed to horseradish
peroxidase conjugated anti-£uorescein antibody.
Staining was developed in diaminobenzidine and sec-
tions were counterstained with Mayer’s hematoxylin.
2.5. Isolation and gel electrophoresis of DNA
Liver was homogenized in lysis bu¡er containing
50 mM Tris-HCl (pH 7.5), 10 mM EDTA and 0.5%
sodium dodecyl sulfate, and incubated overnight
with proteinase K (200 Wg/ml) at 50‡C. After RNase
digestion, DNA was extracted with NaI solution [27]
and electrophoresed on 2% agarose gel using a bu¡er
containing 40 mM borate (pH 7.4) and 1 mM
EDTA.
2.6. Isolation and Northern blot analysis of RNA
Total RNA was extracted from the liver in 4 M
guanidinium isothiocyanate [28] and fractionated by
a⁄nity chromatography on an oligo(dT)-cellulose
column to obtain poly(A)-rich RNA. The concen-
trations of RNA samples were measured by absorb-
ance at 260 nm. The purities of RNA samples were
determined by the ratio of A260nm/A280nm (s 1.8) and
by electrophoresis in formaldehyde-agarose gels
stained with ethidium bromide. The RNA prepara-
tions were denatured and electrophoresed on 1.2%
agarose/2.2 M formaldehyde gels. After separation,
the RNA was transferred to gene screen membranes
by capillary blotting. Hybridization was carried out
using Dig labeled RNA probes and the chemilumi-
nescent signals were quantitated by a densitometer as
described previously [11]. Equal lane loading and the
transfer e⁄ciency of RNA samples were veri¢ed by
the intensity of ethidium bromide £uorescence of the
rRNA on the gel and the ¢lter. The comparable lev-
els of albumin mRNA which do not vary during 24 h
after PH were also con¢rmed in RNA samples used
for blotting [29,30].
2.7. Preparation of RNA probe
The EcoRI/NotI fragment (1.8 kb) of the rat
TGase II cDNA, the EcoRI/PstI fragment (1.8 kb)
of c-jun (ATCC 63026), the PstI fragment (1.0 kb) of
c-fos (ATCC 41040), the EcoRI/EcoRV fragment
(0.86 kb) of mouse RARK cDNA, the BamHI frag-
ment (1.8 kb) of mouse RARL cDNA, the BamHI/
EcoRI fragment (1.8 kb) of mouse RARQ cDNA, the
BamHI fragment (0.9 kb) of mouse RXRK cDNA,
the EcoRI/HindIII fragment (1.4 kb) of mouse
RXRL cDNA, the EcoRI fragment (1.5 kb) of mouse
RXRQ cDNA, the EcoRI fragment (0.85 kb) of
mouse p21 cDNA, the HindIII/AccI fragment
(1.3 kb) of mouse p53 cDNA (RDB 1284), the PstI
fragment (0.7 kb) of mouse TS cDNA, the EcoRI/
PstI fragment (0.8 kb) of rat TK cDNA or the PstI
fragment (0.5 kb) of rat albumin cDNA were sub-
cloned into plasmid Bluescript. After linearization of
the plasmid, T7 RNA polymerase was employed to
obtain run-o¡ transcripts of the antisense strands.
Transcription and labeling were performed utilizing
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the commercial DIG RNA labeling system according
to the manufacturer’s instructions.
3. Results
3.1. E¡ects of RA on the activities of TS and TK, the
DNA, RNA and protein content, and the liver
weight of regenerating liver
The activities of TS and TK at 24 h after PH are
shown in Table 1. The TS activity increased to about
8-fold the normal value (resting in G0 state; just
after PH). When RA was injected immediately after
PH at a dose level of 15 mg/kg body weight, TS
activity decreased to 33% of the control value. TK
activity was also depressed by the injection of RA to
17% of the control. The decreases in TS and TK
activities were followed by signi¢cant reduction of
the increase in liver DNA content. The RNA content
and gross parameters such as protein content and
liver weight were also reduced signi¢cantly. These
inhibitory e¡ects on TS and TK activity and DNA
contents were also observed by the administration of
RA at 2 h or 4 h after PH. When RA was injected at
8 h after PH, however, the regenerative inhibition
was not observed at all. These results indicated that
RA exerted the antiproliferative activity on regener-
ating liver at the priming stage within 4 h after PH.
When the dose level of RA was reduced to 2 mg/kg
body weight, the inhibitions of TS and TK activities
and DNA content were less but signi¢cant. At the
dose level of 0.5 mg of RA/kg body weight, the in-
hibitory e¡ects on liver regeneration were not ob-
served. These results showed that the inhibition of
liver regeneration by RA was dose dependent as
well as time dependent.
Fig. 1. Analysis of DNA fragmentation by agarose gel electro-
phoresis. RA (15 mg/kg body weight) was intraperitoneally in-
jected immediately after PH. Genomic DNA was isolated from
liver of the control (lanes 1^5) and RA injected (lanes 6^10) rat
at 2, 4, 8, 12, and 24 h after PH. Lane M contained HindIII di-
gested V DNA as molecular size marker. Lanes 1^5 were DNA
from the control at 2, 4, 8, 12 and 24 h after PH, respectively.
Lanes 6^10 were DNA from the RA injected rat liver at 2, 4,
8, 12, and 24 h after PH, respectively. The result presented here
is typical of four separate experiments.
Table 1
The e¡ects of retinoic acid on liver regeneration after partial hepatectomy
Treatment Dose
(mg/kg)
Injection time
(h after PH)
Enzymatic activity
(pmol/min/mg of protein)
Total liver content (mg) Liver weight
(g)
TS TK DNA RNA Protein
Control 82.4 þ 5.0 373.1 þ 34.6 7.69 þ 0.15 44.8 þ 1.7 569.4 þ 12.5 3.1 þ 0.07
RA 15 0 27.1 þ 5.1* 63.6 þ 13.4* 5.93 þ 0.37* 34.0 þ 1.9* 474.6 þ 13.0* 2.8 þ 0.05*
15 2 43.2 þ 8.6* 86.7 þ 12.0* 6.16 þ 0.36* 40.9 þ 3.0 601.6 þ 42.2 3.1 þ 0.10
15 4 54.6 þ 3.4* 157.1 þ 12.1* 6.32 þ 0.25* 43.7 þ 1.3 583.3 þ 26.3 3.2 þ 0.13
15 8 73.4 þ 2.2 306.3 þ 36.3 7.48 þ 0.36 43.8 þ 3.3 603.8 þ 21.0 3.1 þ 0.09
2 0 62.7 þ 4.0* 238.1 þ 23.8* 7.08 þ 0.15* 42.7 þ 2.1 523.9 þ 12.7 3.0 þ 0.07
0.5 0 75.7 þ 5.7 361.0 þ 72.3 7.41 þ 0.45 42.5 þ 0.6 563.7 þ 21.6 3.1 þ 0.10
Normal (just
after PH)
10.4 þ 0.8* 34.4 þ 6.9* 5.81 þ 0.20* 33.1 þ 1.9* 476.6 þ 10.2* 2.6 þ 0.04*
RA (15, 2 or 0.5 mg/kg body weight) was intraperitoneally injected at 0, 2, 4 or 8 h after PH. At 24 h after PH, the activities of TS
and TK, the content of DNA, RNA, and protein, and liver weight were determined as described in Section 2.
Values are means þ S.E.M. of 5^8 rats.
*Signi¢cant di¡erence from the control (P6 0.05).
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3.2. Apoptosis induced by RA
RA, injected immediately after PH, induced the
DNA fragmentation as shown in Fig. 1. Agarose
gel electrophoresis revealed a characteristic ladder
pattern of DNA in the RA injected rat liver (Fig.
1). DNA isolated from the control rat liver yielded
bands only in the high molecular weight region. A
Fig. 2. In situ end labeling of the apoptotic bodies in a liver section of RA injected (upper) and control rat (lower) at 8 h after PH.
RA (15 mg/kg body weight) was intraperitoneally injected immediately after PH. Paraformaldehyde ¢xed para⁄n embedded liver sec-
tions, obtained from the regenerating liver of RA injected and control rats at 8 h after PH were processed for in situ detection of
DNA fragmentation by TUNEL as described in Section 2. TUNEL stained nuclei are marked by arrows. Hematoxylin counterstain-
ing. The results presented here are typical of four separate experiments. Magni¢cation U400.
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time course study of DNA fragmentation showed
that signi¢cant DNA cleavage started at 4 h and
peaked at 8 h after PH in RA injected rat liver.
Fig. 2 is a representative example of in situ labeling
of apoptotic cells in a liver section from the control
and RA injected rat at 8 h after PH. TUNEL pos-
itive staining was observed in nuclei and nuclear
fragments with the morphological characteristics of
apoptosis in the RA injected rat liver, with negligible
background staining in the control. The identi¢ca-
tion of stained apoptotic bodies was con¢rmed by
speci¢c morphological criteria including nuclear con-
densation, cytoplasmic compaction and detachment
from neighboring cells [31]. In the present evaluation,
hepatocytes with necrotic morphology were a rare
occurrence and foci of in£ammatory cells were ab-
sent under light microscopy after hematoxylin and
eosin staining.
3.3. E¡ects of RA on the activities of serum GOT and
liver TGase II
As a functional assay substantiating that the e¡ect
of RA is apoptotic and not necrotic, GOT release
was determined as a marker of membrane integrity.
The administration of RA had no signi¢cant e¡ect
on serum GOT activity during liver regeneration as
shown in Table 2, indicating that necrosis was not
caused by RA up to 24 h after PH at the dose level
employed.
A rise in tissue transglutaminase activity has been
described as a prominent feature of some cells under-
going chemically induced apoptotic cell death [32^
34]. To examine the relation between apoptosis and
transglutaminase activation in our system, the time
course of TGase II activity of the liver was measured
during regeneration after PH. The TGase II activity
signi¢cantly increased over control values after 8 h,
at which the DNA fragmentation peaked (Fig. 1),
and kept on increasing to 24 h as shown in Table
2. These results showed that RA induced apoptosis
with concomitant increase of TGase II activity dur-
ing liver regeneration.
3.4. E¡ects of RA on gene expression during liver
regeneration
To address that the increase in TGase II activity
occurred at the transcriptional level, the mRNA lev-
els of TGase II in RA injected rat were compared
with those of the control during liver regeneration.
Northern blot analysis showed that the RA injection
caused marked increases in TGase II mRNA levels at
4 h and the increasing continued up to 24 h to about
15^20-fold the normal value (Fig. 3A; lanes 7^10).
This indicated that the up-regulation of TGase II
activity by RA injection was caused by the increase
in its mRNA level.
The e¡ects of RA on p53 and p21 mRNA levels
were examined. The level of p53 mRNA increased at
8 h peaking at 8^12 h after PH (about 3^5-fold over
the normal value) as shown in Fig. 3A. RA injection
did not cause a signi¢cant change in the p53 expres-
sion pattern during liver regeneration (Fig. 3A, lanes
6^10). p21 mRNA was barely detectable in normal
liver. After PH, a biphasic pattern of p21 expression
Table 2
The e¡ects of retinoic acid on the activities of serum GOT and liver TGase II after partial hepatectomy
Time after PH (h) GOT (IU) TGase II (nmol/h/mg protein)
Control RA Control RA
2 52.3 þ 8.3 45.3 þ 6.3 4.24 þ 0.20 3.50 þ 0.21
4 108.7 þ 5.5 107.5 þ 7.4 4.58 þ 0.19 4.79 þ 0.47
8 116.1 þ 4.1 111.1 þ 9.4 4.83 þ 0.28 6.81 þ 0.49*
12 116.0 þ 16.5 101.2 þ 9.1 4.85 þ 0.36 9.01 þ 1.19*
24 100.7 þ 3.5 107.3 þ 4.5 4.98 þ 0.64 13.66 þ 0.31*
Normal 18.1 þ 0.2 4.24 þ 0.21
RA (15 mg/kg body weight) was intraperitoneally injected immediately after PH. At 2, 4, 8, 12, and 24 h after PH, the activities of se-
rum GOT and liver TGase II were determined as described in Section 2.
Values are means þ S.E.M. of 3^5 rats.
*Signi¢cant di¡erence from the control (P6 0.05).
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was observed as shown in Fig. 3A. The p21 mRNA
levels increased at 2^4 h, declined to the normal level
at 8^12 h, and increased again at 24 h after PH. The
level and pattern of p21 mRNA in RA injected rats
were similar to those in the control (Fig. 3A, lanes 6^
10).
The changes of the mRNA levels of RARK, L, Q
and RXRK, L, Q by RA injection were investigated
(Fig. 3A). The RARK probe hybridized to two
mRNA species of 3.7 kb and 2.8 kb as shown in
Fig. 3A. The RARK mRNA levels decreased at 2 h
and returned to the normal level at 12 and 24 h after
PH in the control, while the constant level was ob-
served in RA injected rats. The RARL mRNA (3.3
kb and 3.0 kb) levels decreased at 8^12 h and recov-
ered to the normal level at 24 h after PH. In contrast
to the control, the RARL mRNA level in RA in-
jected rat markedly increased at 2 h after PH to
about 6-fold the corresponding control value. The
RARQ mRNA (3.3 kb) was barely detectable in the
normal liver and increased to about 10-fold the nor-
mal at 8 h to 24 h after PH. In RA injected rats, the
RARQ mRNA level remarkably increased at 2 h after
PH. Densitometric analysis showed that RA in-
creased the RARQ mRNA level at 2 h to 6^8-fold
the corresponding control value. The levels and pat-
terns of RXRK, L, Q mRNA expression in RA in-
jected rats were similar to those in the control as
shown in Fig. 3A.
The e¡ects of RA on the expression of the imme-
diate early response genes c-fos and c-jun were
studied. The c-fos mRNA levels were barely detect-
able in the normal liver and increased rapidly and
markedly at 15 min and 30 min after PH as shown
in Fig. 3B (lanes N, 1 and 2). RA remarkably sup-
pressed these increases (Fig. 3B, lanes 5 and 6). Scan-
ning densitometry showed that the level of c-fos
mRNA in RA injected liver decreased to about
20% of the control. The levels of c-jun transcripts
increased to about 10-fold the normal value at 15
min and 30 min after PH as shown in Fig. 3B (lanes
N, 1 and 2). RA also blocked the induction of the c-
jun mRNA to 20^30% of the control. These results
clearly demonstrated that RA repressed the expres-
sion of c-fos and c-jun in regenerating liver at the
priming stage.
The e¡ects of RA on the expressions of RARK, L
and Q at the early stage within 2 h during liver re-
generation were also examined (Fig. 3B). The levels
of RARK mRNA decreased at 1 and 2 h after PH in
the control but did not signi¢cantly changed in RA
injected rats during 2 h after PH. The RARL mRNA
levels of RA injected rat were similar to those of the
control until 1 h and markedly increased (8^12-fold
the normal) at 2 h after PH. The RARQ mRNA
levels also markedly increased from 1 h to 2 h (6^
8-fold the normal) by RA injection.
The mRNA levels of TS and TK were barely de-
tectable in the normal quiescent liver and increased
at 24 h after PH as previously reported [11^13].
Northern blot analysis showed that RA inhibited
the increase in 1.3 kb TS mRNA level at 24 h to
30% of the control value proportionally to the TS
activity (Fig. 3C). The levels of 2.6 kb and 1.1 kb
mRNA of TK were also reduced by RA injection in
proportion to the decrease in the activity.
4. Discussion
This study clearly demonstrated that RA exerted
the antiproliferative activity only on the early stage
C
Fig. 3. E¡ects of RA on the expression of TGase II, p53, p21, RARK, L, Q, RXRK, L, Q, c-fos, c-jun, TS and TK during liver regener-
ation after PH. Poly(A)-rich RNA (5 Wg) from the control or RA injected liver at 0^24 h after PH was analyzed by Northern blot
analysis using Dig labeled RNA probes as described in Section 2. (A) Northern blot of TGase II, p53, p21, RARK, L, Q, and RXRK,
L, Q. Lane N, normal; lanes 1^5, the control at 2, 4, 8, 12, and 24 h after PH; lanes 6^10, RA injected rat liver at 2, 4, 8, 12, and 24
h after PH. (B) Northern blot of c-fos, c-jun and RARK, L, Q. Lane N, normal; lanes 1^4, the control at 15 min, 0.5, 1 and 2 h after
PH; lanes 5^8, RA injected rat liver at 15 min, 0.5, 1 and 2 h after PH. (C) Northern blot of TS and TK mRNA. Lane N, normal;
lane C, the control at 24 h after PH; lane RA, RA injected rat liver at 24 h after PH. The photographs of the gel exhibiting ethidium
bromide £uorescence are shown in the right panel, demonstrating equal loading of RNA samples. The comparable levels of albumin
mRNA in RNA samples used for the blotting are also shown by the blot hybridized with albumin probe. The results presented here
are typical of four separate experiments.
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Fig. 3 (continued)
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of regenerating liver and induced apoptosis. When
RA was injected within 4 h after PH, it decreased
the activities of the rate determining enzymes of
DNA synthesis, TS and TK and the subsequent
DNA content at 24 h after PH (Table 1). The injec-
tion of RA at 8 h after PH did not cause the inhib-
itory e¡ects on liver regeneration at all. These indi-
cated that RA exerted its antiproliferative activity on
the liver cells only at the ‘priming’ stage (G0/G1
transition) during regeneration. The regenerative in-
hibition was accompanied by apoptosis. The charac-
teristic DNA fragmentation was observed as early as
4 h and peaked at 8 h after PH (Fig. 1). The results
of in situ end labeling also showed appearance of
apoptotic cells with speci¢c morphological criteria
(Fig. 2). The possibility of necrosis was excluded by
the morphological analysis and serum GOT level.
These results showed that RA induced apoptosis in
liver during normal cell proliferation as in many tu-
mor derived cultured cell systems [4^6,15^18],
although the dose used in this study was at the phar-
macological level.
RA induced apoptosis was preceded by the inhib-
ition of the decrease in the RARK expression and by
the upregulation of RARQ and RARL mRNA levels
within 2 h after PH. The decrease in the RARK
mRNA levels at 1 and 2 h after PH was not observed
in RA injected rats (Fig. 3B). The changes in RARK,
L, Q expression after PH suggest the physiological
role of RA in liver regeneration. The decrease in
RARK expression at the early stage of liver regener-
ation may be needed to induce the proliferation. In
liver cell proliferation, it is also suggested that the
RARK is involved in the control of proliferation
[35,36], whereas RARL controls events that lead to
cellular di¡erentiation [35]. The physiological roles
for RA induced increases in RARL and Q expression
are not known. RARL contains the retinoic acid re-
sponsive element and is inducible, while RARK is not
inducible [37,38]. The administration of RA to nor-
mal rats caused the overexpression of RARL tran-
scripts, although the levels of RARK and RARQ
mRNAs were not a¡ected [37,39]. However, in this
study, the increase in the expression of RARQ as well
as RARL by RA injection was observed within 2 h
after PH as shown in Fig. 3B. RARQ mRNA was
barely detectable in normal liver (Fig. 3 and [39]).
The tissue distribution of the RARQ transcripts is
restricted [40]. The phenotypic changes demonstrated
by null mutant mice of all RARQ isoforms may be
explained by the perturbation of apoptosis during
development [41,42]. The experiments using receptor
selective retinoids showed that the induction of apop-
tosis in neuroblastoma cells was under the control of
RARK and RARQ [43]. Retinoids induced apoptosis
in T cells through the stimulation of RARQ and the
RARQ mediated apoptosis was accompanied with the
increase in the expression of TGase II [44]. The
TGase II mRNA level and activity of RA injected
rat liver also increased at 4 h and 8 h after PH,
respectively (Table 2 and Fig. 3A). Taking these re-
sults together, the increase in RARQ expression ob-
served suggests that RARQ may be involved in RA
induced apoptosis in regenerating liver.
The increase in TGase II expression by RA was
associated with apoptosis during liver regeneration.
RA injection also increased TGase II activity, but
did not cause apoptosis in normal liver [45,46]. These
results suggest that RA induced apoptosis is trig-
gered in actively cycling cells, not in nonproliferating
and fully di¡erentiated cells. This may be important
in explaining some of the antitumor e¡ects of RA.
In agreement with the result that RA act on the
liver cell at early stage during regeneration, the ex-
pressions of the immediate early response proto-on-
cogenes, c-fos and c-jun were markedly repressed by
RA (Fig. 3B). The down-regulation of c-fos expres-
sion by RA associated with growth arrest was also
reported in a ¢brosarcoma cell line [47]. In addition
to the repression of the c-fos mRNA level, the reduc-
tion of c-jun expression observed suggests decreases
in the products of these genes, Fos and Jun proteins,
the principal AP-1 components. In fact, it is reported
that AP-1 activity increased proportionally to the
increase in c-jun mRNA levels in regenerating liver
[48]. The AP-1 transcription factor has been shown
to be essential for DNA replication [49]. In this
study, the levels of TS and TK mRNA which are
induced at G1/S were also decreased by RA in ac-
cord with the down regulation of c-fos and c-jun
mRNA (Fig. 3C). Furthermore, a correlation be-
tween the presence of AP-1 DNA binding activity
and the repression of the cell death pathway was
reported in lymphocytes [50]. On the other hand,
RA caused accumulation of Hep 3B cells in sub-G1
phase during apoptosis and the G0/G1 transition was
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suggested to be the main control check point [19].
These suggest that the expression of c-fos and c-jun
and the subsequent AP-1 activity play an essential
role in determining whether a cell will progress
through the cell cycle or undergo apoptosis. It is
possible that the repression of c-fos and c-jun expres-
sion by RA induces apoptosis during liver regenera-
tion after PH.
Molecular details of apoptosis pathway are still
poorly de¢ned, but recent studies indicate that apop-
tosis is regulated by the balance of various molecules
including tumor suppressor genes, proto-oncogenes,
and cell cycle regulators. The p53 tumor suppressor
gene and the cyclin dependent kinase inhibitor
p21WAF1=CIP1 are known to participate in apoptosis
[51]. In this experiment, however, RA did not in£u-
ence the transcription of p53 and p21WAF1=CIP1 gene.
There was a striking similarity with respect to the
gene expression of these negative regulators of the
cell cycle between proliferative processes and RA in-
duced apoptosis processes in regenerating liver.
In conclusion, our paper has provided evidence
that RA is able to induce apoptosis accompanied
by the repression of the expression of c-fos and c-
jun during liver regeneration after PH and the induc-
tion of apoptosis may contribute to the antiprolifer-
ative activity of RA against regenerating liver at the
early stage. Further study remains necessary, how-
ever, to clarify the molecular mechanisms regulating
RA induced suppression of the proto-oncogene ex-
pression and apoptosis.
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